AMONDYS 45 (casimersen) Sarepta theraps inc Patent: 10,533,174 Expiration: May 4, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Expirations for t…
Drug Patent Expirations for the Week of May 2, 2021 Read Post »
Annual Drug Patent Expirations for QINLOCK Qinlock is a drug marketed by Deciphera Pharms and is included in one NDA. There are three patents protecting this drug. This drug has…
The post New patent for Deciphera Pharms drug QINLOCK appeared first on D…
Expiring drug patents are continuously driving innovation, as branded firms seek out new high-margin opportunities. Examining the patent expirations by year can indicate which pharmaceutical companies face the most peril…
The post Drugs facing the most…
Drugs facing the most patent expirations this year Read Post »
Annual Drug Patent Expirations for EPIDIOLEX Epidiolex is a drug marketed by Gw Res Ltd and is included in one NDA. It is available from one supplier. There are fifteen…
The post New patent for Gw Res drug EPIDIOLEX appeared first on DrugPatentWatch – …
Annual Drug Patent Expirations for TRUVADA Truvada is a drug marketed by Gilead and is included in one NDA. It is available from seven suppliers. There are six patents protecting…
The post New patent expiration for Gilead drug TRUVADA appeared first on…
Annual Drug Patent Expirations for TRUVADA Truvada is a drug marketed by Gilead and is included in one NDA. It is available from seven suppliers. There are six patents protecting…
The post New patent expiration for Gilead drug TRUVADA appeared first on…
Annual Drug Patent Expirations for STRIBILD Stribild is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are thirteen…
The post New patent expiration for Gilead Sciences drug STRIBILD appeared …
New patent expiration for Gilead Sciences drug STRIBILD Read Post »
Annual Drug Patent Expirations for STRIBILD Stribild is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are thirteen…
The post New patent expiration for Gilead Sciences drug STRIBILD appeared …
New patent expiration for Gilead Sciences drug STRIBILD Read Post »
Annual Drug Patent Expirations for ODEFSEY Odefsey is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are ten…
The post New patent expiration for Gilead Sciences drug ODEFSEY appeared first on…
New patent expiration for Gilead Sciences drug ODEFSEY Read Post »
Annual Drug Patent Expirations for GENVOYA Genvoya is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from two suppliers. There are thirteen…
The post New patent expiration for Gilead Sciences drug GENVOYA appeared fi…
New patent expiration for Gilead Sciences drug GENVOYA Read Post »
Get new actionable insights and updates from BiotechBlog
